Brain health is essential for maintaining focus, memory, and overall cognitive function. However, many people experience ...

Men at high risk of cardiovascular disease had brain volume changes a decade earlier than women, U.K. Biobank data showed.

Brain volume loss linked to new Alzheimer’s immunotherapies, such as lecanemab, is caused by the removal of amyloid plaques rather than neuronal damage.

A new study indicates that the loss of brain volume associated with the Alzheimer's drug lecanemab shows the drug is working ...

Neurophet, an artificial intelligence (AI) solution company for brain disease, announced on the 25th that its brain MRI analysis software "Neurophet AQUA", has obtained 510(k) clearance from U.S. Food ...

"Modify your diet and lifestyle to reduce the risk of developing heart problems and obesity; this will reduce the likelihood ...

Men with cardiovascular disease risk factors, including obesity, face brain health decline a decade earlier—from their mid ...

But for religious people especially, the loss of our collective desire and aptitude to read good books well is lamentable.

Fast Track designation indicates LBS-007’s potential in filling the unmet medical need of acute leukemia; LBS-007 is the Company’s investigational medicinal product for the tr ...

MTV show 'Catfish' host discusses training and running the 2024 New York City marathon after a near-fatal bike-truck accident ...

ReviR Therapeutics, a pioneering biotechnology company focused on developing novel small molecule RNA modulators for neurogenetic diseases, announced a groundbreaking research grant ...

The Company currently has four primary drug candidates under development, including LBS-008 (for Geographic Atrophy [GA] in advanced dry age-related macular degeneration ... and LBS-002 (for primary ...